2023
DOI: 10.1101/2023.03.19.533306
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

An Ensemble Learning Approach to perform Link Prediction on Large Scale Biomedical Knowledge Graphs for Drug Repurposing and Discovery

Abstract: Generating knowledge graph embeddings (KGEs) to represent entities (nodes) and relations (edges) in large scale knowledge graph datasets has been a challenging problem in representation learning. This is primarily because the embeddings / vector representations that are required to encode the full scope of data in a large heterogeneous graph needs to have a high dimensionality. The orientation of a large number of vectors requires a lot of space which is achieved by projecting the embeddings to higher dimensio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
3
1
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 40 publications
0
1
0
Order By: Relevance
“…KGE offers several advantages over alternative methods for link prediction, including edge type awareness, the use of higher-order patterns, scalability, and improved accuracy over feature-based approaches (Mohamed, Nounu, and Nováček 2021). KGEs have been successfully used in drug discovery tasks (Mohamed, Nounu, and Nováček 2019; Bonner, Kirik, et al 2022) (Zitnik, Agrawal, and Leskovec 2018) (Prabhakar et al 2023). The same methods used for these pharmaceutical-specific tasks can also be directly applied to rare disease variant prioritization.…”
Section: Introductionmentioning
confidence: 99%
“…KGE offers several advantages over alternative methods for link prediction, including edge type awareness, the use of higher-order patterns, scalability, and improved accuracy over feature-based approaches (Mohamed, Nounu, and Nováček 2021). KGEs have been successfully used in drug discovery tasks (Mohamed, Nounu, and Nováček 2019; Bonner, Kirik, et al 2022) (Zitnik, Agrawal, and Leskovec 2018) (Prabhakar et al 2023). The same methods used for these pharmaceutical-specific tasks can also be directly applied to rare disease variant prioritization.…”
Section: Introductionmentioning
confidence: 99%